239 related articles for article (PubMed ID: 17701214)
1. Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan.
Goissen C; Ghyselen L; Tourneux P; Krim G; Storme L; Bou P; Maingourd Y
Eur J Pediatr; 2008 Apr; 167(4):437-40. PubMed ID: 17701214
[TBL] [Abstract][Full Text] [Related]
2. Surgical repair of transposition of the great arteries in neonates with persistent pulmonary hypertension.
Luciani GB; Chang AC; Starnes VA
Ann Thorac Surg; 1996 Mar; 61(3):800-5. PubMed ID: 8619696
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of persistent pulmonary hypertension of the newborn with bosentan.
Nakwan N; Choksuchat D; Saksawad R; Thammachote P; Nakwan N
Acta Paediatr; 2009 Oct; 98(10):1683-5. PubMed ID: 19523174
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Interstitial Glycogenosis: A Reversible Underlying Condition Associated With D-Transposition of the Great Arteries and Severe Persistent Pulmonary Hypertension.
Sanchez-de-Toledo J; González-Peris S; Gran F; Gregoraci A; Ferreres JC; Ruiz CW; Balcells J; Abella RF
World J Pediatr Congenit Heart Surg; 2015 Jul; 6(3):480-3. PubMed ID: 26180171
[TBL] [Abstract][Full Text] [Related]
5. Persistent Pulmonary Hypertension in a Neonate With Transposition of Great Arteries and Intact Ventricular Septum: A Case Report and Review of the Literature.
Karimi M; Kirshbom PM; Kopf GS; Steele MM; Sullivan JM
World J Pediatr Congenit Heart Surg; 2015 Jul; 6(3):462-5. PubMed ID: 26180166
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of portopulmonary hypertension with bosentan: case report.
Stähler G; von Hunnius P
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():62-6. PubMed ID: 16919013
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of bosentan treatment for portopulmonary hypertension associated with syncope.
Sato A; Maie K; Ohno Y; Yoshida T; Ito E; Tanabe Y; Aizawa Y
Int Heart J; 2011; 52(4):243-5. PubMed ID: 21828952
[TBL] [Abstract][Full Text] [Related]
8. Preoperative ECMO in transposition of the great arteries with persistent pulmonary hypertension.
Jaillard S; Belli E; Rakza T; Larrue B; Magnenant E; Rey C; Storme L
Ann Thorac Surg; 2005 Jun; 79(6):2155-8. PubMed ID: 15919337
[TBL] [Abstract][Full Text] [Related]
9. Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension.
Halank M; Miehlke S; Hoeffken G; Schmeisser A; Schulze M; Strasser RH
Transplantation; 2004 Jun; 77(11):1775-6. PubMed ID: 15201684
[No Abstract] [Full Text] [Related]
10. Successful treatment with bosentan for pulmonary hypertension and reduced peripheral circulation in juvenile systemic sclerosis.
Shimizu M; Hashida Y; Ueno K; Yokoyama T; Nakayama Y; Saito T; Ohta K; Takehara K; Yachie A
Pediatr Cardiol; 2011 Oct; 32(7):1040-2. PubMed ID: 21789477
[TBL] [Abstract][Full Text] [Related]
11. Persistent pulmonary hypertension of the newborn with transposition of the great arteries.
Roofthooft MT; Bergman KA; Waterbolk TW; Ebels T; Bartelds B; Berger RM
Ann Thorac Surg; 2007 Apr; 83(4):1446-50. PubMed ID: 17383355
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension.
Fox B; Langleben D; Hirsch AM; Schlesinger RD; Eisenberg MJ; Joyal D; Blenkhorn F; Lesenko L
Can J Cardiol; 2013 Jun; 29(6):672-7. PubMed ID: 22819360
[TBL] [Abstract][Full Text] [Related]
13. Late presenters with dextro-transposition of great arteries and intact ventricular septum: to train or not to train the left ventricle for arterial switch operation?
Parker NM; Zuhdi M; Kouatli A; Baslaim G
Congenit Heart Dis; 2009; 4(6):424-32. PubMed ID: 19925535
[TBL] [Abstract][Full Text] [Related]
14. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease.
Benza RL; Rayburn BK; Tallaj JA; Coffey CS; Pinderski LJ; Pamoukian SV; Bourge RC
Chest; 2006 Apr; 129(4):1009-15. PubMed ID: 16608951
[TBL] [Abstract][Full Text] [Related]
16. Effect of bosentan therapy in persistent pulmonary hypertension of the newborn.
Maneenil G; Thatrimontrichai A; Janjindamai W; Dissaneevate S
Pediatr Neonatol; 2018 Feb; 59(1):58-64. PubMed ID: 28735030
[TBL] [Abstract][Full Text] [Related]
17. Successful management of the persistent pulmonary hypertension of the newborn with transposition of the great arteries by restricted patency of the ductus arteriosus: a simple and rational novel strategy.
Masutani S; Seki M; Taketazu M; Senzaki H
Pediatr Cardiol; 2009 Oct; 30(7):1003-5. PubMed ID: 19495850
[TBL] [Abstract][Full Text] [Related]
18. [Endothelin receptor antagonist bosentan. Breakthrough in the treatment of pulmonary hypertension].
MMW Fortschr Med; 2004 Dec; 146(50):72-3. PubMed ID: 15666438
[No Abstract] [Full Text] [Related]
19. Nitric oxide in neonatal transposition of the great arteries.
El-Segaier M; Hellström-Westas L; Wettrell G
Acta Paediatr; 2005 Jul; 94(7):912-6. PubMed ID: 16188814
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic observations in two pulmonary hypertensive patients changing treatment from inhaled iloprost to the oral endothelin-antagonist bosentan.
Fruhwald FM; Kjellström B; Perthold W; Wonisch M; Maier R; Klein W
J Heart Lung Transplant; 2005 May; 24(5):631-4. PubMed ID: 15896766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
